22.30Open22.30Pre Close0 Volume0 Open Interest135.00Strike Price0.00Turnover253.80%IV-46.00%PremiumDec 20, 2024Expiry Date57.81Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9694Delta0.0034Gamma1.33Leverage Ratio-0.1263Theta-0.0103Rho-1.29Eff Leverage0.0059Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet